GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » PE Ratio

Rite Aid (Rite Aid) PE Ratio

: At Loss (As of Today)
View and export this data going back to 1970. Start your Free Trial

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-04-19), Rite Aid's share price is $0.12. Rite Aid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was $-29.62. Therefore, Rite Aid's PE Ratio for today is At Loss.

During the past 13 years, Rite Aid's highest PE Ratio was 114.55. The lowest was 0.00. And the median was 16.47.

Rite Aid's EPS (Diluted) for the three months ended in Aug. 2023 was $-18.44. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was $-29.62.

As of today (2024-04-19), Rite Aid's share price is $0.12. Rite Aid's EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2023 was $-9.50. Therefore, Rite Aid's PE Ratio without NRI ratio for today is At Loss.

During the past 13 years, Rite Aid's highest PE Ratio without NRI was 165.33. The lowest was 0.00. And the median was 23.56.

Rite Aid's EPS without NRI for the three months ended in Aug. 2023 was $-7.39. Its EPS without NRI for the trailing twelve months (TTM) ended in Aug. 2023 was $-9.50.

During the past 13 years, Rite Aid's highest 3-Year average EPS without NRI Growth Rate was 175.90% per year. The lowest was -225.00% per year. And the median was 9.40% per year.

Rite Aid's EPS (Basic) for the three months ended in Aug. 2023 was $-18.44. Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2023 was $-29.62.

Back to Basics: PE Ratio


Rite Aid PE Ratio Historical Data

The historical data trend for Rite Aid's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison

For the Pharmaceutical Retailers subindustry, Rite Aid's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid PE Ratio Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's PE Ratio distribution charts can be found below:

* The bar in red indicates where Rite Aid's PE Ratio falls into.



Rite Aid PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Rite Aid's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=0.12/-29.620
=-0(At Loss)

Rite Aid's Share Price of today is $0.12.
Rite Aid's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.62.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Rite Aid  (OTCPK:RADCQ) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Rite Aid PE Ratio Related Terms

Thank you for viewing the detailed overview of Rite Aid's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402